Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changes.
Saved in:
| Title: | Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changes. |
|---|---|
| Authors: | Hammerslag LR; Institute for Biomedical Informatics, College of Medicine, University of Kentucky, United States of America; Department of Internal Medicine, College of Medicine, University of Kentucky, United States of America. Electronic address: l.hammerslag@uky.edu., Talbert J; Institute for Biomedical Informatics, College of Medicine, University of Kentucky, United States of America; Department of Internal Medicine, College of Medicine, University of Kentucky, United States of America., Slavova S; Department of Biostatistics, College of Public Health, University of Kentucky, United States of America., Lei F; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, United States of America., Freeman PR; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, United States of America., Marks KR; Department of Behavioral Science, College of Medicine, University of Kentucky, United States of America., Fanucchi LC; Department of Internal Medicine, College of Medicine, University of Kentucky, United States of America; Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, United States of America., Walsh SL; Department of Behavioral Science, College of Medicine, University of Kentucky, United States of America; Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, United States of America., Lofwall MR; Department of Behavioral Science, College of Medicine, University of Kentucky, United States of America; Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, United States of America. |
| Source: | Journal of substance use and addiction treatment [J Subst Use Addict Treat] 2024 Sep; Vol. 164, pp. 209391. Date of Electronic Publication: 2024 May 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918541186406676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2949-8759 (Electronic) Linking ISSN: 29498759 NLM ISO Abbreviation: J Subst Use Addict Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
